{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:13:05Z","timestamp":1793387585989,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T00:00:00Z","timestamp":1732492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Regional Scholarship and Innovation Fund (RSIF), through the Partnership for Skills in Applied Sciences, Engineering and Technology"},{"name":"CeZAP ID-IGEP graduate student mini-grant 2023"},{"name":"OR Tambo Africa Research Chair for Viral Epidemics"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Newcastle disease virus (NDV) is an extremely contagious and deadly virus that affects numerous bird species, posing serious threats to poultry production on a global scale. In addition to implementing biosecurity practices in farming systems, vaccination remains the most effective means of controlling Newcastle disease (ND). However, while existing commercial vaccines provide some level of protection, the effectiveness of these vaccines can be questionable, particularly in field settings where the complexity of vaccination program implementation poses significant challenges, especially against virulent genotypes of NDV. A genotype-matched NDV DNA vaccine could potentially offer a more effective vaccination approach than currently available live attenuated vaccines. By being specifically tailored to match circulating strains, such a vaccine might improve efficacy and reduce the risk of vaccine failure due to genotype mismatch. To develop an alternative vaccine approach, two ND DNA vaccines were constructed in this study. Each vaccine developed in this study contains the fusion (F) and haemagglutinin-neuraminidase (HN) genes of a virulent NDV genotype VII isolate from Tanzania. Interferon lambda-3 (IFN\u03bb3; IL-28b), which has demonstrated capacity to significantly enhance specific adaptive immune responses and decreased levels of inflammatory cytokines, as well as improved protective responses at a high viral challenge dose, was included in one of the developed vaccines. These plasmids were designated pTwist-F-HN-VII-IL28b and pTwist-F-HN-VII. The two plasmids differed in that pTwist-F-HN-VII-IL28b contained the cytokine adjuvant IL-28b. Transfection of cells and subsequent immunofluorescence assays indicated that both plasmids expressed high levels of NDV F-HN proteins. In vivo immunization demonstrated that chicks intramuscularly immunized with pTwist-F-HN-VII-IL28b exhibited significant immune responses compared to chicks immunized with pTwist-F-HN-VII or the commonly used LaSota vaccine (LaSota), which was used as a control. The protective efficacy of pTwist-F-HN-VII-IL28b was 80% after challenge with the highly virulent NDV strain ON148423, compared to 60% for chicks vaccinated using LaSota, and pTwist-F-HN-VII. The findings of this study indicate that IL-28b can be employed as a molecular adjuvant for NDV vaccines. This study represents a key milestone in Newcastle disease vaccine research, particularly in the development of a genotype-matched DNA vaccine candidate. Additionally, this study demonstrated that the combination of F, HN, and IL-28b elicits an efficacious immune response against virulent NDV strains.<\/jats:p>","DOI":"10.1007\/s11259-024-10590-y","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T05:07:18Z","timestamp":1732511238000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Development of a genotype-matched Newcastle disease DNA vaccine candidate adjuvanted with IL-28b for the control of targeted velogenic strains of Newcastle disease virus in Africa"],"prefix":"10.1007","volume":"49","author":[{"given":"Charlie F.","family":"Amoia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augustino A.","family":"Chengula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean N.","family":"Hakizimana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philemon N.","family":"Wambura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Munir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Misinzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Weger-Lucarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,25]]},"reference":[{"key":"10590_CR1","doi-asserted-by":"publisher","unstructured":"Absal\u00f3n AE, Cort\u00e9s-espinosa DV, Lucio E et al (2019) Epidemiology, control, and prevention of newcastle disease in endemic regions: Latin America. Trop Animal Health Prod 51:1033\u20131048. https:\/\/doi.org\/10.1007\/s11250-019-01843-z","DOI":"10.1007\/s11250-019-01843-z"},{"key":"10590_CR2","doi-asserted-by":"publisher","first-page":"477","DOI":"10.3390\/vetsci10070477","volume":"10","author":"CF Amoia","year":"2023","unstructured":"Amoia CF, Hakizimana JN, Duggal NK et al (2023) Genetic Diversity of Newcastle Disease Virus involved in the 2021 outbreaks in Backyard Poultry Farms in Tanzania. Vet Sci 10:477. https:\/\/doi.org\/10.3390\/vetsci10070477","journal-title":"Vet Sci"},{"key":"10590_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/v16050795","volume":"16","author":"CF Amoia","year":"2024","unstructured":"Amoia CF, Hakizimana JN, Chengula AA et al (2024a) Genomic Diversity and Geographic Distribution of Newcastle Disease Virus genotypes in Africa: implications for diagnosis, vaccination, and Regional collaboration. Viruses 16:795. https:\/\/doi.org\/10.3390\/v16050795","journal-title":"Viruses"},{"key":"10590_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s44338-024-00015-0","volume":"1","author":"CF Amoia","year":"2024","unstructured":"Amoia CF, Hakizimana JN, Chengula AA et al (2024b) Phylogenetic analysis of virulent strains of the Newcastle Disease virus isolated from deceased chickens in Tanzania\u2019s Morogoro and Iringa regions. Discov Anim 1:1\u201311. https:\/\/doi.org\/10.1007\/s44338-024-00015-0","journal-title":"Discov Anim"},{"key":"10590_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.3390\/vaccines8020270","volume":"8","author":"MB Bello","year":"2020","unstructured":"Bello MB, Mahamud SNA, Yusoff K et al (2020) Development of an effective and stable genotype-matched live attenuated newcastle disease virus vaccine based on a novel naturally recombinant Malaysian isolate using reverse genetics. Vaccines 8:270. https:\/\/doi.org\/10.3390\/vaccines8020270","journal-title":"Vaccines"},{"key":"10590_CR6","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nmeth.4223","volume":"14","author":"J Birnbaum","year":"2017","unstructured":"Birnbaum J, Flemming S, Reichard N et al (2017) A genetic system to study Plasmodium falciparum protein function. Nat Methods 14:450\u2013456. https:\/\/doi.org\/10.1038\/nmeth.4223","journal-title":"Nat Methods"},{"key":"10590_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13567-017-0475-9","volume":"48","author":"VR Brown","year":"2017","unstructured":"Brown VR, Bevins SN (2017) A review of virulent Newcastle disease viruses in the United States and the role of wild birds in viral persistence and spread. Vet Res 48:1\u201315. https:\/\/doi.org\/10.1186\/s13567-017-0475-9","journal-title":"Vet Res"},{"key":"10590_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-017-0900-8","volume":"14","author":"A Chumbe","year":"2017","unstructured":"Chumbe A, Izquierdo-Lara R, Calder\u00f3n K et al (2017) Development of a novel Newcastle Disease virus (NDV) neutralization test based on recombinant NDV expressing enhanced green fluorescent protein. Virol J 14:1\u201311. https:\/\/doi.org\/10.1186\/s12985-017-0900-8","journal-title":"Virol J"},{"key":"10590_CR9","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3389\/fimmu.2016.00427","volume":"7","author":"A Ciabattini","year":"2016","unstructured":"Ciabattini A, Pettini E, Fiorino F et al (2016) Modulation of primary immune response by different vaccine adjuvants. Front Immunol 7:427. https:\/\/doi.org\/10.3389\/fimmu.2016.00427","journal-title":"Front Immunol"},{"key":"10590_CR10","unstructured":"CSIRO (2020) Poultry production in Tanzania\u2013 LiveGAPS. https:\/\/research.csiro.au\/livegaps\/findings\/livestock-production\/poultry-production-in-tanzania\/. Accessed 17 Jul 2024"},{"key":"10590_CR11","doi-asserted-by":"publisher","unstructured":"da Silva AP, Aston EJ, Chiwanga GH et al (2020) Molecular characterization of newcastle disease viruses isolated from chickens in Tanzania and Ghana. Viruses 12. https:\/\/doi.org\/10.3390\/v12090916","DOI":"10.3390\/v12090916"},{"key":"10590_CR12","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1099\/0022-1317-80-1-131","volume":"80","author":"O De Leeuw","year":"1999","unstructured":"De Leeuw O, Peeters B (1999) Complete nucleotide sequence of Newcastle Disease virus: evidence for the existence of a new genus within the subfamily Paramyxovirinae. J Gen Virol 80:131\u2013136. https:\/\/doi.org\/10.1099\/0022-1317-80-1-131","journal-title":"J Gen Virol"},{"key":"10590_CR13","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1128\/JCM.03044-15","volume":"54","author":"KM Dimitrov","year":"2016","unstructured":"Dimitrov KM, Lee DH, Williams-Coplin D et al (2016) Newcastle disease viruses causing recent outbreaks worldwide show unexpectedly high genetic similarity to historical virulent isolates from the 1940s. J Clin Microbiol 54:1228\u20131235. https:\/\/doi.org\/10.1128\/JCM.03044-15","journal-title":"J Clin Microbiol"},{"key":"10590_CR14","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.vetmic.2016.12.019","volume":"206","author":"KM Dimitrov","year":"2017","unstructured":"Dimitrov KM, Afonso CL, Yu Q, Miller PJ (2017) Newcastle disease vaccines\u2014A solved problem or a continuous challenge? Vet Microbiol 206:126\u2013136. https:\/\/doi.org\/10.1016\/j.vetmic.2016.12.019","journal-title":"Vet Microbiol"},{"key":"10590_CR15","doi-asserted-by":"publisher","first-page":"103917","DOI":"10.1016\/j.meegid.2019.103917","volume":"74","author":"KM Dimitrov","year":"2019","unstructured":"Dimitrov KM, Abolnik C, Afonso CL et al (2019) Updated unified phylogenetic classification system and revised nomenclature for Newcastle Disease virus. Infect Genet Evol 74:103917. https:\/\/doi.org\/10.1016\/j.meegid.2019.103917","journal-title":"Infect Genet Evol"},{"key":"10590_CR16","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.vetmic.2014.05.004","volume":"172","author":"JCFM Dortmans","year":"2014","unstructured":"Dortmans JCFM, Venema-Kemper S, Peeters BPH, Koch G (2014) Field vaccinated chickens with low antibody titres show equally insufficient protection against matching and non-matching genotypes of virulent Newcastle Disease virus. Vet Microbiol 172:100\u2013107. https:\/\/doi.org\/10.1016\/j.vetmic.2014.05.004","journal-title":"Vet Microbiol"},{"key":"10590_CR17","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.bjbas.2017.04.004","volume":"6","author":"SS Ewies","year":"2017","unstructured":"Ewies SS, Ali A, Tamam SM, Madbouly HM (2017) Molecular characterization of Newcastle Disease virus (genotype VII) from broiler chickens in Egypt. Beni-Suef Univ J Basic Appl Sci 6:232\u2013237. https:\/\/doi.org\/10.1016\/j.bjbas.2017.04.004","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"10590_CR18","doi-asserted-by":"publisher","first-page":"113","DOI":"10.30466\/vrf.2019.95311.2295","volume":"11","author":"M Fawzy","year":"2020","unstructured":"Fawzy M, Ali RR, Elfeil WK et al (2020) Efficacy of inactivated velogenic newcastle disease virus genotype vii vaccine in broiler chickens. Vet Res Forum 11:113\u2013120. https:\/\/doi.org\/10.30466\/vrf.2019.95311.2295","journal-title":"Vet Res Forum"},{"key":"10590_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines9020182","volume":"9","author":"HL Ferreira","year":"2021","unstructured":"Ferreira HL, Miller PJ, Suarez DL (2021) Protection against different genotypes of newcastle disease viruses (ndv) afforded by an adenovirus-vectored fusion protein and live ndv vaccines in chickens. Vaccines 9:1\u201318. https:\/\/doi.org\/10.3390\/vaccines9020182","journal-title":"Vaccines"},{"key":"10590_CR20","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.jbiotec.2016.03.037","volume":"231","author":"J Ge","year":"2016","unstructured":"Ge J, Liu Y, Jin L et al (2016) Construction of recombinant baculovirus vaccines for Newcastle Disease virus and an assessment of their immunogenicity. J Biotechnol 231:201\u2013211. https:\/\/doi.org\/10.1016\/j.jbiotec.2016.03.037","journal-title":"J Biotechnol"},{"key":"10590_CR21","doi-asserted-by":"crossref","unstructured":"Hassanzadeh M, Abedi M, Bashashati M et al (2024) Evaluation of the newcastle disease virus genotype VII\u2013mismatched vaccines in SPF chickens: a challenge efficacy study. Vet Anim Sci 24","DOI":"10.1016\/j.vas.2024.100348"},{"key":"10590_CR22","doi-asserted-by":"publisher","first-page":"e0209539","DOI":"10.1371\/journal.pone.0209539","volume":"14","author":"R Izquierdo-Lara","year":"2019","unstructured":"Izquierdo-Lara R, Chumbe A, Calder\u00f3n K et al (2019a) Genotype-matched Newcastle Disease virus vaccine confers improved protection against genotype XII challenge: the importance of cytoplasmic tails in viral replication and vaccine design. PLoS ONE 14:e0209539. https:\/\/doi.org\/10.1371\/journal.pone.0209539","journal-title":"PLoS ONE"},{"key":"10590_CR23","doi-asserted-by":"publisher","unstructured":"Izquierdo-Lara R, Chumbe A, Calder\u00f3n K et al (2019b) Genotype-matched Newcastle Disease virus vaccine confers improved protection against genotype XII challenge: the importance of cytoplasmic tails in viral replication and vaccine design. PLoS ONE 14. https:\/\/doi.org\/10.1371\/journal.pone.0209539","DOI":"10.1371\/journal.pone.0209539"},{"key":"10590_CR24","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.jbiotec.2014.01.016","volume":"173","author":"BJ Jordan","year":"2014","unstructured":"Jordan BJ, Vogel S, Stark MR, Beckstead RB (2014) Expression of green fluorescent protein in the chicken using in vivo transfection of the piggyBac transposon. J Biotechnol 173:86\u201389. https:\/\/doi.org\/10.1016\/j.jbiotec.2014.01.016","journal-title":"J Biotechnol"},{"key":"10590_CR25","doi-asserted-by":"publisher","first-page":"3424","DOI":"10.1016\/j.vaccine.2005.01.140","volume":"23","author":"DR Kapczynski","year":"2005","unstructured":"Kapczynski DR, King DJ (2005) Protection of chickens against overt clinical disease and determination of viral shedding following vaccination with commercially available Newcastle Disease virus vaccines upon challenge with highly virulent virus from the California 2002 exotic Newcastl. Vaccine 23:3424\u20133433. https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.140","journal-title":"Vaccine"},{"key":"10590_CR26","doi-asserted-by":"publisher","first-page":"1272402","DOI":"10.3389\/fvets.2023.1272402","volume":"10","author":"HM Kariithi","year":"2023","unstructured":"Kariithi HM, Volkening JD, Chiwanga GH et al (2023) Virulent Newcastle Disease virus genotypes V.3, VII.2, and XIII.1.1 and their coinfections with infectious bronchitis viruses and other avian pathogens in backyard chickens in Tanzania. Front Vet Sci 10:1272402. https:\/\/doi.org\/10.3389\/fvets.2023.1272402","journal-title":"Front Vet Sci"},{"issue":"7","key":"10590_CR27","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3390\/v8070183","volume":"8","author":"SH Kim","year":"2016","unstructured":"Kim SH, Samal SK (2016) Newcastle Disease virus as a vaccine vector for development of human and veterinary vaccines. Viruses 8(7):183. https:\/\/doi.org\/10.3390\/v8070183","journal-title":"Viruses"},{"key":"10590_CR28","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1080\/14760584.2023.2292772","volume":"23","author":"DN Kisakov","year":"2024","unstructured":"Kisakov DN, Belyakov IM, Kisakova LA et al (2024) The use of electroporation to deliver DNA-based vaccines. Expert Rev Vaccines 23:102\u2013123. https:\/\/doi.org\/10.1080\/14760584.2023.2292772","journal-title":"Expert Rev Vaccines"},{"key":"10590_CR29","unstructured":"Lamb RA, Parks GD (2007) Paramyxoviridae: the viruses and their replication. In: Fields BN, Knipe DN, Howley\u00a0PM (eds) Fields virology, 5th edn. Lippincott, Williams, and Wilkins,\u00a0pp 1449\u20131496"},{"key":"10590_CR30","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s11250-018-1679-3","volume":"51","author":"JF Lindahl","year":"2019","unstructured":"Lindahl JF, Young J, Wyatt A et al (2019) Do vaccination interventions have effects? A study on how poultry vaccination interventions change smallholder farmer knowledge, attitudes, and practice in villages in Kenya and Tanzania. Trop Anim Health Prod 51:213\u2013220. https:\/\/doi.org\/10.1007\/s11250-018-1679-3","journal-title":"Trop Anim Health Prod"},{"key":"10590_CR31","doi-asserted-by":"publisher","DOI":"10.1201\/b19719","volume-title":"Molecular Detection of Animal Viral Pathogens","author":"D Liu","year":"2015","unstructured":"Liu D (2015) Molecular detection of animal viral pathogens, 1st edn. CRC. https:\/\/doi.org\/10.1201\/b19719","edition":"1"},{"key":"10590_CR32","doi-asserted-by":"publisher","unstructured":"Lu S, Grimes-Serrano JM, Wang S (2008) DNA vaccines for Biodefense and Emerging and neglected infectious diseases. Vaccines Biodefense Emerg Neglected Dis 93\u2013114. https:\/\/doi.org\/10.1016\/B978-0-12-369408-9.00008-1","DOI":"10.1016\/B978-0-12-369408-9.00008-1"},{"key":"10590_CR33","doi-asserted-by":"publisher","first-page":"1332939","DOI":"10.3389\/fimmu.2024.1332939","volume":"15","author":"B Lu","year":"2024","unstructured":"Lu B, Lim JM, Yu B et al (2024) The next-generation DNA vaccine platforms and delivery systems: advances, challenges and prospects. Front Immunol 15:1332939. https:\/\/doi.org\/10.3389\/fimmu.2024.1332939","journal-title":"Front Immunol"},{"key":"10590_CR34","doi-asserted-by":"publisher","unstructured":"Luke GA, Ryan MD (2018) Therapeutic applications of the \u2018NPGP\u2019 family of viral 2As. Rev Med Virol 28. https:\/\/doi.org\/10.1002\/rmv.2001","DOI":"10.1002\/rmv.2001"},{"key":"10590_CR35","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1099\/vir.0.83428-0","volume":"89","author":"GA Luke","year":"2008","unstructured":"Luke GA, de Felipe P, Lukashev A et al (2008) Occurrence, function and evolutionary origins of 2A-like sequences in virus genomes. J Gen Virol 89:1036\u20131042. https:\/\/doi.org\/10.1099\/vir.0.83428-0","journal-title":"J Gen Virol"},{"key":"10590_CR36","doi-asserted-by":"publisher","unstructured":"Mallampalli RK, Adair J, Elhance A et al (2021) Interferon Lambda Signaling in Macrophages is necessary for the antiviral response to Influenza. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.735576","DOI":"10.3389\/fimmu.2021.735576"},{"key":"10590_CR37","doi-asserted-by":"publisher","first-page":"5974","DOI":"10.1016\/j.vaccine.2017.09.008","volume":"35","author":"J Mayers","year":"2017","unstructured":"Mayers J, Mansfield KL, Brown IH (2017) The role of vaccination in risk mitigation and control of Newcastle disease in poultry. Vaccine 35:5974\u20135980. https:\/\/doi.org\/10.1016\/j.vaccine.2017.09.008","journal-title":"Vaccine"},{"key":"10590_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2298\/bah1701001m","volume":"33","author":"N Milic","year":"2017","unstructured":"Milic N, Nisavic J, Zoric A et al (2017) Overview of current advances in the development of subunit and recombinant vaccines against Newcastle Disease virus. Biotechnol Anim HusbandryBiotehnologija u Stoc 33:1\u201311. https:\/\/doi.org\/10.2298\/bah1701001m","journal-title":"Biotechnol Anim HusbandryBiotehnologija u Stoc"},{"key":"10590_CR39","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.dci.2013.06.007","volume":"41","author":"PJ Miller","year":"2013","unstructured":"Miller PJ, Afonso CL, El Attrache J et al (2013) Effects of Newcastle Disease virus vaccine antibodies on the shedding and transmission of challenge viruses. Dev Comp Immunol 41:505\u2013513. https:\/\/doi.org\/10.1016\/j.dci.2013.06.007","journal-title":"Dev Comp Immunol"},{"key":"10590_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.virusres.2018.12.014","volume":"261","author":"A Mohebbi","year":"2019","unstructured":"Mohebbi A, Ebrahimzadeh MS, Baghban Rahimi S et al (2019) Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression. Virus Res 261:72\u201380. https:\/\/doi.org\/10.1016\/j.virusres.2018.12.014","journal-title":"Virus Res"},{"key":"10590_CR41","doi-asserted-by":"publisher","first-page":"1714","DOI":"10.1038\/mt.2010.118","volume":"18","author":"MP Morrow","year":"2010","unstructured":"Morrow MP, Yan J, Pankhong P et al (2010) IL-28B\/IFN\u03bb-3 drives granzyme B loading and significantly increases CTL killing activity in macaques. Mol Ther 18:1714\u20131723. https:\/\/doi.org\/10.1038\/mt.2010.118","journal-title":"Mol Ther"},{"key":"10590_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/tbed.14121","volume":"69","author":"MM Naguib","year":"2021","unstructured":"Naguib MM, H\u00f6per D, Elkady MF et al (2021) Comparison of genomic and antigenic properties of Newcastle Disease virus genotypes II, XXI and VII from Egypt do not point to antigenic drift as selection marker. Transbound Emerg Dis 69:1\u201316. https:\/\/doi.org\/10.1111\/tbed.14121","journal-title":"Transbound Emerg Dis"},{"key":"10590_CR43","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/nar\/gkm1102","volume":"36","author":"S Nakagawa","year":"2008","unstructured":"Nakagawa S, Niimura Y, Gojobori T et al (2008) Diversity of preferred nucleotide sequences around the translation initiation codon in eukaryote genomes. Nucleic Acids Res 36:861\u2013871. https:\/\/doi.org\/10.1093\/nar\/gkm1102","journal-title":"Nucleic Acids Res"},{"key":"10590_CR44","unstructured":"OIE (2012) Manual of diagnostic tests and vaccines for terrestrial animals: mammals, birds and bees. Biological standards Commission. World Organization for Animal Health, Paris, pp 1\u201319"},{"key":"10590_CR45","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.virol.2021.08.014","volume":"563","author":"P Rai","year":"2021","unstructured":"Rai P, Chuong C, LeRoith T et al (2021) Adenovirus transduction to express human ACE2 causes obesity-specific morbidity in mice, impeding studies on the effect of host nutritional status on SARS-CoV-2 pathogenesis. Virology 563:98\u2013106. https:\/\/doi.org\/10.1016\/j.virol.2021.08.014","journal-title":"Virology"},{"key":"10590_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1099\/vir.0.83391-0","volume":"89","author":"RE Randall","year":"2008","unstructured":"Randall RE, Goodbourn S (2008) Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89:1\u201347. https:\/\/doi.org\/10.1099\/vir.0.83391-0","journal-title":"J Gen Virol"},{"issue":"6","key":"10590_CR47","doi-asserted-by":"publisher","first-page":"1195","DOI":"10.3390\/v14061195","volume":"14","author":"R Ravikumar","year":"2022","unstructured":"Ravikumar R, Chan J, Prabakaran M (2022) Vaccines against major poultry viral diseases: strategies to improve the Breadth and Protective Efficacy. Viruses 14(6):1195. https:\/\/doi.org\/10.3390\/v14061195","journal-title":"Viruses"},{"key":"10590_CR48","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed LJ, Muench H (1938a) A simple method of estimating fifty per cent endpoints. Am J Epidemiol 27:493\u2013497. https:\/\/doi.org\/10.1093\/oxfordjournals.aje.a118408","journal-title":"Am J Epidemiol"},{"key":"10590_CR49","first-page":"493","volume":"27","author":"JL Reed","year":"1938","unstructured":"Reed JL, Muench H (1938b) A simple method for estimating 50% endpoints. Am J Hyg 27:493\u2013497","journal-title":"Am J Hyg"},{"key":"10590_CR50","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1128\/jvi.02764-13","volume":"88","author":"A Reuter","year":"2014","unstructured":"Reuter A, Soubies S, H\u00e4rtle S et al (2014) Antiviral activity of Lambda Interferon in chickens. J Virol 88:2835\u20132843. https:\/\/doi.org\/10.1128\/jvi.02764-13","journal-title":"J Virol"},{"key":"10590_CR51","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00705-017-3336-y","volume":"162","author":"AM Saad","year":"2017","unstructured":"Saad AM, Samy A, Soliman MA et al (2017) Genotypic and pathogenic characterization of genotype VII Newcastle disease viruses isolated from commercial farms in Egypt and evaluation of heterologous antibody responses. Arch Virol 162:1985\u20131994. https:\/\/doi.org\/10.1007\/s00705-017-3336-y","journal-title":"Arch Virol"},{"key":"10590_CR52","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s00705-020-04900-3","volume":"166","author":"A Sabbaghi","year":"2021","unstructured":"Sabbaghi A, Zargar M, Zolfaghari MR et al (2021) Protective cellular and mucosal immune responses following nasal administration of a whole gamma-irradiated influenza A (subtype H1N1) vaccine adjuvanted with interleukin-28B in a mouse model. Arch Virol 166:545\u2013557. https:\/\/doi.org\/10.1007\/s00705-020-04900-3","journal-title":"Arch Virol"},{"key":"10590_CR53","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1080\/03079457.2018.1488240","volume":"47","author":"E Shahar","year":"2018","unstructured":"Shahar E, Haddas R, Goldenberg D et al (2018) Newcastle Disease virus: is an updated attenuated vaccine needed? Avian Pathol 47:467\u2013478. https:\/\/doi.org\/10.1080\/03079457.2018.1488240","journal-title":"Avian Pathol"},{"key":"10590_CR54","doi-asserted-by":"publisher","unstructured":"Sladitschek HL, Neveu PA (2015) MXS-chaining: a highly efficient cloning platform for imaging and flow cytometry approaches in mammalian systems. PLoS ONE 10. https:\/\/doi.org\/10.1371\/journal.pone.0124958","DOI":"10.1371\/journal.pone.0124958"},{"key":"10590_CR55","doi-asserted-by":"publisher","first-page":"1130910","DOI":"10.3389\/fpls.2023.1130910","volume":"14","author":"T Smith","year":"2023","unstructured":"Smith T, O\u2019Kennedy MM, Ross CS et al (2023) The production of Newcastle Disease virus-like particles in Nicotiana benthamiana as potential vaccines. Front Plant Sci 14:1130910. https:\/\/doi.org\/10.3389\/fpls.2023.1130910","journal-title":"Front Plant Sci"},{"key":"10590_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s00705-008-0269-5","volume":"154","author":"CJ Snoeck","year":"2009","unstructured":"Snoeck CJ, Ducatez MF, Owoade AA et al (2009) Newcastle Disease virus in West Africa: New virulent strains identified in non-commercial farms. Arch Virol 154:47\u201354. https:\/\/doi.org\/10.1007\/s00705-008-0269-5","journal-title":"Arch Virol"},{"key":"10590_CR57","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.psj.2019.10.063","volume":"99","author":"HA Sultan","year":"2020","unstructured":"Sultan HA, Talaat S, Elfeil WK et al (2020) Protective efficacy of the Newcastle Disease virus genotype VII\u2013matched vaccine in commercial layers. Poult Sci 99:1275\u20131286. https:\/\/doi.org\/10.1016\/j.psj.2019.10.063","journal-title":"Poult Sci"},{"key":"10590_CR58","doi-asserted-by":"publisher","unstructured":"Sultan HA, Elfeil WK, Nour AA et al (2022) Efficacy of the newcastle disease virus genotype vii.1.1-matched vaccines in commercial broilers. Vaccines 10. https:\/\/doi.org\/10.3390\/vaccines10010029","DOI":"10.3390\/vaccines10010029"},{"key":"10590_CR59","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1101\/pdb.ip067876","volume":"7","author":"AL Szymczak-Workman","year":"2012","unstructured":"Szymczak-Workman AL, Vignali KM, Vignali DAA (2012) Design and construction of 2A peptide-linked multicistronic vectors. Cold Spring Harb Protoc 7:199\u2013204. https:\/\/doi.org\/10.1101\/pdb.ip067876","journal-title":"Cold Spring Harb Protoc"},{"key":"10590_CR60","doi-asserted-by":"publisher","first-page":"100440","DOI":"10.1016\/j.jvacx.2024.100440","volume":"16","author":"MS Taghizadeh","year":"2024","unstructured":"Taghizadeh MS, Niazi A, Afsharifar A (2024) Virus-like particles (VLPs): a promising platform for combating against Newcastle Disease virus. Vaccine X 16:100440. https:\/\/doi.org\/10.1016\/j.jvacx.2024.100440","journal-title":"Vaccine X"},{"key":"10590_CR61","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-422X-10-330","volume":"10","author":"DV Umali","year":"2013","unstructured":"Umali DV, Ito H, Suzuki T et al (2013) Molecular epidemiology of Newcastle Disease virus isolates from vaccinated commercial poultry farms in non-epidemic areas of Japan. Virol J 10:1\u201317. https:\/\/doi.org\/10.1186\/1743-422X-10-330","journal-title":"Virol J"},{"key":"10590_CR62","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1017\/S0043933917000411","volume":"73","author":"S Umar","year":"2017","unstructured":"Umar S (2017) Emergence of new sub-genotypes of Newcastle Disease virus in Pakistan. Worlds Poult Sci J 73:567\u2013580. https:\/\/doi.org\/10.1017\/S0043933917000411","journal-title":"Worlds Poult Sci J"},{"key":"10590_CR63","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s11250-018-1607-6","volume":"50","author":"A Wajid","year":"2018","unstructured":"Wajid A, Basharat A, Bibi T, Rehmani SF (2018) Comparison of protection and viral shedding following vaccination with Newcastle Disease virus strains of different genotypes used in vaccine formulation. Trop Anim Health Prod 50:1645\u20131651. https:\/\/doi.org\/10.1007\/s11250-018-1607-6","journal-title":"Trop Anim Health Prod"},{"key":"10590_CR64","doi-asserted-by":"publisher","first-page":"2417","DOI":"10.1007\/s00705-019-04306-w","volume":"164","author":"PJ Walker","year":"2019","unstructured":"Walker PJ, Siddell SG, Lefkowitz EJ et al (2019) Changes to virus taxonomy and the International Code of Virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2019). Arch Virol 164:2417\u20132429. https:\/\/doi.org\/10.1007\/s00705-019-04306-w","journal-title":"Arch Virol"},{"key":"10590_CR65","doi-asserted-by":"publisher","unstructured":"Wallace JW, Constant DA, Nice TJ (2021) Interferon Lambda in the Pathogenesis of Inflammatory Bowel diseases. Front Immunol 12. https:\/\/doi.org\/10.3389\/fimmu.2021.767505","DOI":"10.3389\/fimmu.2021.767505"},{"key":"10590_CR66","doi-asserted-by":"publisher","unstructured":"Williams S, Endacott I, Ekiri AB et al (2022) Barriers to vaccine use in small ruminants and poultry in Tanzania. Onderstepoort J Vet Res 89. https:\/\/doi.org\/10.4102\/ojvr.v89i1.2007","DOI":"10.4102\/ojvr.v89i1.2007"},{"key":"10590_CR67","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1007\/s00705-020-04669-5","volume":"165","author":"P Xie","year":"2020","unstructured":"Xie P, Li YY, Li YY et al (2020) Immune effect of a Newcastle Disease virus DNA vaccine with IL-12 as a molecular adjuvant delivered by electroporation. Arch Virol 165:1959\u20131968. https:\/\/doi.org\/10.1007\/s00705-020-04669-5","journal-title":"Arch Virol"},{"key":"10590_CR68","doi-asserted-by":"publisher","unstructured":"Yang H, Tian J, Zhao J et al (2024) The application of Newcastle disease virus (NDV): vaccine vectors and tumor therapy. Viruses 16:886. https:\/\/doi.org\/10.3390\/V16060886","DOI":"10.3390\/V16060886"},{"key":"10590_CR69","doi-asserted-by":"publisher","first-page":"949","DOI":"10.3390\/v13060949","volume":"13","author":"P Yin","year":"2021","unstructured":"Yin P, Kielian M (2021) Bhk-21 cell clones differ in Chikungunya virus infection and mxra8 receptor expression. Viruses 13:949. https:\/\/doi.org\/10.3390\/v13060949","journal-title":"Viruses"},{"key":"10590_CR70","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13567-022-01118-w","volume":"53","author":"H Zenglei","year":"2022","unstructured":"Zenglei H, Xiaozheng H, Jing D et al (2022) Current situation and future direction of Newcastle disease vaccines. Vet Res 53:99. https:\/\/doi.org\/10.1186\/s13567-022-01118-w","journal-title":"Vet Res"},{"key":"10590_CR71","doi-asserted-by":"publisher","first-page":"e82648","DOI":"10.1371\/journal.pone.0082648","volume":"8","author":"K Zhao","year":"2013","unstructured":"Zhao K, Li W, Huang T et al (2013) Preparation and efficacy of newcastle disease virus DNA vaccine encapsulated in PLGA nanoparticles. PLoS ONE 8:e82648. https:\/\/doi.org\/10.1371\/journal.pone.0082648","journal-title":"PLoS ONE"},{"key":"10590_CR72","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2147\/IJN.S54226","volume":"9","author":"K Zhao","year":"2014","unstructured":"Zhao K, Zhang Y, Zhang X et al (2014) Preparation and efficacy of newcastle disease virus dna vaccine encapsulated in chitosan nanoparticles. Int J Nanomed 9:389\u2013402. https:\/\/doi.org\/10.2147\/IJN.S54226","journal-title":"Int J Nanomed"},{"key":"10590_CR73","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.4014\/jmb.1708.08017","volume":"27","author":"K Zhao","year":"2017","unstructured":"Zhao K, Duan X, Hao L et al (2017) Immune effect of newcastle disease virus DNA vaccine with c3d as a molecular adjuvant. J Microbiol Biotechnol 27:2060\u20132069. https:\/\/doi.org\/10.4014\/jmb.1708.08017","journal-title":"J Microbiol Biotechnol"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-024-10590-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-024-10590-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T10:09:26Z","timestamp":1738404566000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-024-10590-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,25]]},"references-count":73,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["10590"],"URL":"https:\/\/doi.org\/10.1007\/s11259-024-10590-y","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"value":"0165-7380","type":"print"},{"value":"1573-7446","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,25]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"For the vaccine development and in vitro testing, this study was carried out according to the recommendations in the Guide for the Care and Use of Laboratory Animals of the National Institutes of Health. The Institutional Biosafety Committee of Virginia Tech approved the research for the ND DNA vaccine. For the vaccine experimentation on animals, ethical clearance was obtained from the Office of the Vice-Chancellor, Sokoine University of Agriculture, Tanzania and Permission to undertake animal health research in Tanzania from the United Republic of Tanzania Ministry of Livestock and Fisheries (Ref. No. DB.16\/324\/01\/137).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional review board"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}